RSS Novartis: Entresto US Patent Upheld By US Court Of Appeals

Currently reading:
 RSS Novartis: Entresto US Patent Upheld By US Court Of Appeals

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
15,206
Likes
1,923
Credits
33,933©
Cash
0$
On Monday, the Swiss pharmaceutical giant Novartis (NVS) announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has upheld the validity of the patent for the Entresto (sacubitril/valsartan) combination in the United States. The company stated that it intends to rigorously enforce this combination patent, which benefits from pediatric exclusivity until it expires in July 2025.

Novartis emphasized its commitment to defending and safeguarding its key intellectual property and regulatory rights associated with Entresto. The company also pointed out that there are currently no generic versions of Entresto available in the United States.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.

Similar threads

Top Bottom